Sabra Health Care REIT, Inc. (SBRA) Earnings Call Transcripts

28 earnings calls from February 2020 to August 4, 2026

NasdaqGS US Real Estate Health Care REITs

Sabra Health Care REIT, Inc.'s Latest Earnings Call - Q1 FY2026

In the first quarter of 2026, Sabra Health Care REIT, Inc. (SBRA) reported normalized FFO per share of $0.38 and normalized AFFO per share of $0.39, reflecting increases of 9% and 5% year-over-year, respectively. Revenue from the managed senior housing portfolio grew by 7.9% year-over-year, indicating strong operational performance. Management reaffirmed its 2026 earnings guidance, citing ongoing positive trends in occupancy and investment opportunities, while also indicating a potential reevaluation of guidance in Q2 2026.

Reported metrics

MetricValueContext
Normalized FFO per Share $0.38 (beat) vs $0.35 est, +9% YoY
Normalized AFFO per Share $0.39 (beat) vs $0.37 est, +5% YoY
Same-Store Managed Senior Housing Revenue Growth 7.9% (positive) YoY growth
Cash NOI from Managed Senior Housing Portfolio $39 million (positive) vs $35.6 million last quarter, +10.2% QoQ
Total Investments Year-to-Date $400 million (positive) with an additional $690 million actively pursued
Quarterly Cash Dividend $0.30 (positive) payout of 77% of normalized AFFO per share

Guidance from management

Management reaffirmed its 2026 earnings guidance, indicating that current trends support their outlook. They plan to revisit guidance in Q2 2026 based on ongoing performance metrics.

What management said

So yes, we are typically conservative this early in the year, but all the trends are obviously going in the right direction. You see the yields that we're investing in. So that looks good for us as well. So it's really just kind of as simple as that. We'll reevaluate earnings guidance rather for the second quarter.
— Rick Matros, Q1 FY2026 earnings call
Yes. So with respect to the $690 million, these are investment opportunities that we are actively pursuing. These include opportunities where we have submitted an initial LOI and are moving forward in the process. As far as the probability of success, it's hard to tell because it is a bit of a competitive environment, but we would expect to close on a fair number of that investment opportunity.
— Darrin Smith, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the conservatism in management's guidance, questioning what would be needed to reach the lower midpoint. There were also inquiries about the potential impact of the skilled nursing market's competitive environment on future growth.

Main topics on the call

Read the full Sabra Health Care REIT, Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. (SBRA) is a publicly listed company in the Health Care REITs industry, within the Real Estate sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 28 calls on record spanning February 24, 2020 to August 4, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 28 Sabra Health Care REIT, Inc. earnings call transcripts on record, spanning February 24, 2020 to August 4, 2026. Based on this history, Sabra Health Care REIT, Inc. reports quarterly. The most recent call on file is dated August 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
SBRA
Exchange
NasdaqGS
Country
US
Sector
Real Estate
Industry
Health Care REITs
Calls on record
28
First call
February 24, 2020
Most recent
August 4, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 4, 2026 Read transcript
Q1 FY2026 Apr 30, 2026 Read transcript
Q4 FY2025 Feb 13, 2026 Read transcript
Q3 FY2025 Nov 6, 2025 Read transcript
Q2 FY2025 Aug 5, 2025 Read transcript
Q1 FY2025 May 6, 2025 Read transcript
Q4 FY2024 Feb 20, 2025 Read transcript
Q3 FY2024 Nov 1, 2024 Read transcript
Q2 FY2024 Aug 8, 2024 Read transcript
Q1 FY2024 May 9, 2024 Read transcript
Q4 FY2023 Feb 28, 2024 Read transcript
Q3 FY2023 Nov 7, 2023 Read transcript
Q2 FY2023 Aug 8, 2023 Read transcript
Q1 FY2023 May 4, 2023 Read transcript
Q4 FY2022 Feb 22, 2023 Read transcript
Q3 FY2022 Nov 8, 2022 Read transcript
Q2 FY2022 Aug 4, 2022 Read transcript
Q1 FY2022 May 5, 2022 Read transcript
Q4 FY2021 Feb 22, 2022 Read transcript
Q3 FY2021 Nov 4, 2021 Read transcript
Q2 FY2021 Aug 5, 2021 Read transcript
Q1 FY2021 May 6, 2021 Read transcript
Q4 FY2020 Feb 23, 2021 Read transcript
Q3 FY2020 Nov 6, 2020 Read transcript
Q2 FY2020 Aug 6, 2020 Read transcript
Shareholder/Analyst Calls Jun 9, 2020 Read transcript
Q1 FY2020 May 7, 2020 Read transcript
Q4 FY2019 Feb 24, 2020 Read transcript